Cargando…

Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients

The SARS-CoV-2 virus alters the expression of genes for extracellular matrix proteins, including fibronectin. The aim of the study was to establish the relationship between different forms of fibronectin, such as plasma (pFN), cellular (EDA-FN), and proteolytic FN-fragments, and disease severity and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemańska-Perek, Anna, Krzyżanowska-Gołąb, Dorota, Dragan, Barbara, Tyszko, Maciej, Adamik, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100231/ https://www.ncbi.nlm.nih.gov/pubmed/35563870 http://dx.doi.org/10.3390/cells11091566

Ejemplares similares

Plasma and Cellular Forms of Fibronectin as Prognostic Markers in Sepsis
por: Lemańska-Perek, Anna, et al.
Publicado: (2020)

Explainable Artificial Intelligence Helps in Understanding the Effect of Fibronectin on Survival of Sepsis
por: Lemańska-Perek, Anna, et al.
Publicado: (2022)

Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients
por: Tyszko, Maciej, et al.
Publicado: (2022)

Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis
por: Lemańska-Perek, Anna, et al.
Publicado: (2016)

Citrulline, Intestinal Fatty Acid-Binding Protein and the Acute Gastrointestinal Injury Score as Predictors of Gastrointestinal Failure in Patients with Sepsis and Septic Shock
por: Tyszko, Maciej, et al.
Publicado: (2023)

Changes of plasma fibronectin and fibronectin-fibrin complexes in dams of stillborn dairy calves
por: Jawor, Paulina, et al.
Publicado: (2020)

Severe immune thrombocytopenia in a critically ill COVID-19 patient
por: Martincic, Ziga, et al.
Publicado: (2020)

Lactoferrin effects on immune response in critically ill
por: Adamik, B, et al.
Publicado: (1997)

Critical illness neuropathy in severe COVID-19
por: Bocci, Tommaso, et al.
Publicado: (2021)

Very severe COVID-19 in the critically ill in Tunisia
por: Saida, Imen Ben, et al.
Publicado: (2020)

Estimating severe and critical illness in children with COVID-19
por: Salemi, Jason L., et al.
Publicado: (2020)

Platelet Receptor Activity for Predicting Survival in Patients with Intracranial Bleeding
por: Dragan, Barbara, et al.
Publicado: (2021)

Changes in Plasma Fibronectin Isoform Levels Predict Distinct Clinical Outcomes in Critically Ill Patients
por: Peters, John H., et al.
Publicado: (2011)

What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness
por: Miller, Andrew C., et al.
Publicado: (2020)

Immunoinflammatory Response in Critically Ill Patients: Severe Sepsis and/or Trauma
por: Surbatovic, Maja, et al.
Publicado: (2013)

Severe neurological complications in critically ill COVID-19 patients
por: Notz, Quirin, et al.
Publicado: (2020)

Human genetic basis of severe or critical illness in COVID-19
por: Ji, Xiao-Shan, et al.
Publicado: (2022)

Dysbiosis: An Indicator of COVID-19 Severity in Critically Ill Patients
por: Cuenca, Silvia, et al.
Publicado: (2022)

Severe Candida infections in critically ill patients with COVID-19
por: Koulenti, Despoina, et al.
Publicado: (2023)

Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
por: Kujawa, Katarzyna Aleksandra, et al.
Publicado: (2020)

Spiritual care in critically ill patients during COVID-19 pandemic
por: de Diego-cordero, Rocío, et al.
Publicado: (2022)

Thyroid hormone concentrations in severely or critically ill patients with COVID-19
por: Gao, W., et al.
Publicado: (2020)

Severe acute kidney injury in critically ill COVID-19 patients
por: Piñeiro, Gaston J., et al.
Publicado: (2021)

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia
por: Elabbadi, Alexandre, et al.
Publicado: (2021)

Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients
por: Bhandari, Sudhir, et al.
Publicado: (2021)

Critical illness neuropathy in severe COVID-19: a case series
por: Bocci, Tommaso, et al.
Publicado: (2021)

Outcomes of Barotrauma in Critically Ill COVID-19 Patients With Severe Pneumonia
por: Gazivoda, Victor P., et al.
Publicado: (2021)

Critical illness-associated cerebral microbleeds in severe COVID-19 infection()
por: Gupta, Nidhi Azad, et al.
Publicado: (2020)

A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients
por: Huang, Peifeng, et al.
Publicado: (2022)

Biochemical Parameters as Prognostic Markers in Severely Ill COVID-19 Patients
por: Pitamberwale, Anjali, et al.
Publicado: (2022)

Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect?
por: Roedl, Kevin, et al.
Publicado: (2021)

External validation of the sepsis severity score
por: Wełna, Marek, et al.
Publicado: (2020)

Pain in critically ill COVID-19 patients: An Italian retrospective study
por: Petrucci, Emiliano, et al.
Publicado: (2022)

Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro
por: Liu, Xiao-Ya, et al.
Publicado: (2016)

Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19
por: Poignon, C., et al.
Publicado: (2020)

Risk Assessment and Prediction of Severe or Critical COVID-19 Illness in Older Adults
por: Zhang, Xiao-Yu, et al.
Publicado: (2020)

High prevalence of heterotopic ossification in critically ill patients with severe COVID-19
por: Stoira, Elisa, et al.
Publicado: (2021)

Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore
por: Puah, Ser Hon, et al.
Publicado: (2021)

Role of Prealbumin in Predicting the Prognosis of Severely and Critically Ill COVID-19 Patients
por: Cui, Ningning, et al.
Publicado: (2021)

Severe bradycardia in critically ill patients with COVID-19 – A cases report
por: Larue, J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qt6s5rin4h114u6qqal8pud2an